To examine this, primary CD4+ T cells were transduced with TCR1, a high-affinity TCR which we have previously shown can mediate tumor rejection in the context of ACT, or with either TCR16 or TCR18, each of which were isolated from a single FoxP3+ cell. This evidence concerns the gene FOXP3 and neoplasm.